Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
J Immunol ; 143(12): 4188-92, 1989 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-2592771

RESUMEN

The increase of mast cells at sites of tissue inflammation suggests the production of local factors chemotactic for mast cells. In this report, we demonstrate that the murine mast cell line PT18 and primary mouse bone marrow-derived mast cells chemotax to the basement membrane glycoprotein laminin, and that the synthetic laminin A chain-derived peptide, PA22-2, represents a region of laminin that contains a major chemoattractant site. Mast cell chemotaxis to laminin is enhanced after activation of mast cells by the calcium ionophore, A23187, or PMA and by sensitization of the cells with IgE followed by exposure to antigen. Chemotaxis is not increased in the presence of IL-3 and is independent of mast cell degranulation, as histamine release did not occur when cells were activated with PMA. Mast cell chemotaxis to laminin and its enhancement by IgE-dependent mast cell activation provides a mechanism by which these cells may be attracted to sites of tissue injury. Such activity may be particularly relevant in the response of host tissues to inflammation accompanying parasitic infestations, allergic reactions, and wound healing.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Factores Quimiotácticos/farmacología , Inmunoglobulina E/fisiología , Laminina/farmacología , Mastocitos/inmunología , Animales , Línea Celular , Quimiotaxis/efectos de los fármacos , Colágeno/farmacología , Fibronectinas/farmacología , Sueros Inmunes/farmacología , Inmunosupresores/farmacología , Laminina/inmunología , Mastocitos/efectos de los fármacos , Ratones , Péptidos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA